Navigation Links
Exciton Technologies receives FDA approval to market exSALT(TM)
Date:8/5/2009

products, the success and timely completion of clinical studies and trials, the Company's ability to successfully commercialize its products, the ability of the Company to defend its patents from infringement by third parties, and the risk that the Company's patents may be subsequently shown to be invalid or infringe the patents of others. Investors should consult the Company's quarterly and annual filings with the Canadian commissions for additional information on risks and uncertainties relating to the forward- looking statements. Investors are cautioned against placing undue reliance on forward-looking statements.


'/>"/>
SOURCE Exciton Technolgies Inc.
Copyright©2009 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3

Related biology technology :

1. ImmunoVaccine Technologies Partners With Scancell to Advance DNA Vaccine Delivery
2. BioSpecifics Technologies Corp. to Host Conference Call to Report Second Quarter 2009 Financial Results on August 12, 2009
3. Palatin Technologies, Inc. Receives U.S. Patent Allowance for Heart Failure Drug Candidate
4. OmniComm Systems Acquires EDC Assets of Leading Phase I Clinical Software Vendor - Logos Technologies, Ltd.
5. Terrosa Technologies Assigned as Exclusive Reseller for Inclinicalperform CTMS/SaaS Clinical Trials Collaboration Software
6. Senesco Technologies Enters Into Agreements For Additional $700,000 In Financing
7. Debiopharm and MSM Protein Technologies Sign Agreement for Research and Development of Debio 0929, a Novel Oncology Biologic
8. Ricardo Launches Consortium to Evaluate Lubricant Challenges of Future Low Carbon Engine Technologies
9. BioSpecifics Technologies Corp. to Present at CapStone Investments Third Annual Small-Cap Investor Conference
10. DNA Software, Inc. Awarded $2.5 M in NIH Funding to Develop Pioneering Nucleic Acid-based Technologies
11. 4th BTLtec Conference on 24-25 Sep in Graz, Austria features Biomass to Liquids Innovators Sharing Updates on Pyrolysis and Gasification Technologies, Syngas Application, BTL Value Chain and a Site Visit to the Biomass CHP Gussing Plant.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... Amsterdam, May 17, 2013 - Elsevier, a world-leading provider ... today announced the publication of a recent study in ... old human blastocysts showing that those with an abnormal ... which they have developed to blastocysts, thereby classifying the ... new study the same group has undertaken a retrospective ...
(Date:5/17/2013)... 2013 •    First of its kind research ... ,     New facility will help solve crop stresses ... Syngenta unveiled its new crop research facility during ... Innovation Center. The first of its kind, $72 million ... agricultural climate and precisely measure plant inputs – the ...
(Date:5/17/2013)... May 17, 2013  Cellular Biomedicine Group (OTCQB: ... enrollment of the total projected enrollment required for ... and preliminary efficacy of the medical technology haMPC ... Osteoarthritis (KOA). To date the trial has had ... The Phase I open label clinical research trial ...
(Date:5/17/2013)... May 17, 2013 /PRNewswire-iReach/ -- Aridis is pleased ... with Switzerland -based Kenta Biotech ... monoclonal antibody (mAb) products, and technologies. This asset ... for treatment of infections by common pathogens including ... , Pseudomonas aeruginosa , Acinetobacter baumannii ...
Breaking Biology Technology:Breakthrough for IVF? 2Breakthrough for IVF? 3Syngenta Opens Unique $72 Million Advanced Crop Lab 2Syngenta Opens Unique $72 Million Advanced Crop Lab 3Cellular Biomedicine Group Achieves 50% Enrollment Milestone in Phase I Clinical Trial for Knee Osteoarthritis 2Aridis Pharmaceuticals Announces Acquisition of Monoclonal Antibody Products and Technologies From Kenta Biotech 2Aridis Pharmaceuticals Announces Acquisition of Monoclonal Antibody Products and Technologies From Kenta Biotech 3
... Decision Resources, one of the world,s leading research and advisory ... uptake of marketed and emerging TNF-alpha inhibitors and interleukin inhibitors ... billion in 2008 to $5.2 billion in 2018 in the ... Japan. , The new Pharmacor report entitled ...
... ... and related products. Wide range of new peptide synthesis reagents and catalogue peptides. New ... , ... October 22, 2009 -- Mimotopes Pty Ltd, a subsidiary of Commonwealth Biotechnologies Inc. (NASDAQ ...
... , MONTREAL, Oct. 23 /PRNewswire/ - Enerkem, a leading ... Corporate Knights 2009 Next 10 Emerging Cleantech Leaders. Vincent ... the other Cleantech companies at today,s Toronto Stock Exchange ... Cleantech Next 10 list features Canada,s best privately held ...
Cached Biology Technology:Continued Uptake of TNF-Alpha Inhibitors and Interleukin Inhibitors Will Drive $2.2 Billion Growth in the Psoriasis Drug Market 2Mimotopes Launches Online Peptide Superstore 2Mimotopes Launches Online Peptide Superstore 3Enerkem Named an Emerging Cleantech Leader in Canada 2
(Date:5/16/2013)... us don,t ponder our pulses outside of the gym. But ... monitor heart health. , Zhenan Bao, a professor of chemical ... a dollar bill and no wider than a postage stamp. ... the wrist, is sensitive enough to help doctors detect stiff ... be used to continuously track heart health and provide doctors ...
(Date:5/16/2013)... May 16, 2013 The consultancy ... on Tuesday to Germany,s largest ... border control system. DERMALOG has been honored ... Practices Award in the category Global Biometrics and Border ... Biometric   Border Control System . One of ...
(Date:5/15/2013)... that have powerful behavioral effects on diverse organisms ... ecosystems, according to a theory proposed in the ... of the theory, Ryan P. Ferrer of Seattle ... University of California at Los Angeles, liken such ... may be uncommon but exert a controlling influence, ...
Breaking Biology News(10 mins):Stanford engineers monitor heart health using paper-thin flexible 'skin' 2Stanford engineers monitor heart health using paper-thin flexible 'skin' 3Global Biometrics and Border Control Award for DERMALOG 2Global Biometrics and Border Control Award for DERMALOG 3Global Biometrics and Border Control Award for DERMALOG 4Natural 'keystone molecules' punch over their weight in ecosystems 2
... Partnership, in partnership with the LUNGevity Foundation, is pleased ... grant competition. The research grants, each $100,000, ... biology, risk assessment, prevention, detection, and response to treatment. ... generous donors, were able to offer researchers critical funding ...
... LAKE CITY Two major eye diseases and leading causes ... or even prevented by drugs that activate a protein ... of Utah School of Medicine and several other institutions ... both diseases was prevented and even reversed when the ...
... a systems biological analysis of genome-scale data from ... researchers identified that the master gene controlling the ... study will appear in the latest issue of ... This hypothesis derived from multi-network analysis of Arabidopsis ...
Cached Biology News:National Lung Cancer Partnership and LUNGevity Foundation 2Blood vessel protein reverses macular degeneration, diabetic retinopathy in mice 2Blood vessel protein reverses macular degeneration, diabetic retinopathy in mice 3Systems biology approach identifies nutrient regulation of biological clock in plants 2
...
Rabbit polyclonal to Quinolinic acid ( Abpromise for all tested applications). Antigen: Synthetic quinolinic acid conjugated to bovine serum albumin....
Human Cell Line Slides...
Tris-EDTA Buffer Solution, 1X, pH 8.0, sterile...
Biology Products: